Table 5.2.9FOSQ in randomized controlled trials of CPAP vs. sham control

Study
PMID
Baseline AHI (SD) [eligibility]Baseline ESS (SD)Duration (design)InterventionsNo. AnalyzedBaseline (SD)Final (SD)Net diff95% CIP BtwDropout, %Study Quality
Barbe 2001142
11388814
57 (15) [≥30]7.0 (2)6 wk (PL)CPAP29102 (16)108 (11)+4.0−3.3, 11.3 *NS2B
Sham CPAP25107 (15)110 (10)
Montserrat 2001162
11520724
54 (19) [>10]16.9 (5.6)6 wk (PL)CPAP2385 (22)109 (13)+10.48−2.6, 23.6 NS6B
Sham CPAP2286 (28)101 (22)
Marshall 2005159
15860720
22 (nd) [nd]12.5 (4.3)3 wk (XO)CPAP2912.6 (1.6)13.6 (1.8)−0.3−1.1, 0.5NS6B
Sham CPAP2912.6 (1.6)13.3 (1.8)
*

Estimated from reported data.

Estimated from reported data.

From: Appendix D, Summary Tables

Cover of Diagnosis and Treatment of Obstructive Sleep Apnea in Adults
Diagnosis and Treatment of Obstructive Sleep Apnea in Adults [Internet].
Comparative Effectiveness Reviews, No. 32.
Balk EM, Moorthy D, Obadan NO, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.